Multiple Myeloma
Item
newly diagnosis of multiple myeloma
boolean
C0026764 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) status 0-3,
boolean
C1520224 (UMLS CUI [1])
Survival time Estimated
Item
estimated survival time > 3 months
boolean
C2919552 (UMLS CUI [1,1])
C0750572 (UMLS CUI [1,2])
Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
acceptable liver function (bilirubin＜2.5×uln, alanine transaminase (alt) or aspartate aminotransferase (ast)＜2.5×uln)
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
Malignant Neoplasms Other
Item
no history of other malignancies
boolean
C0006826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Prior Therapy | Chemotherapy Regimen | Therapeutic radiology procedure | Targeted Therapy | Stem cell transplant
Item
no previous treatments including chemotherapy, radiotherapy, targeted therapy or stem cell transplantation
boolean
C1514463 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C2985566 (UMLS CUI [4])
C1504389 (UMLS CUI [5])
Disease Interferes with Clinical Trial Therapeutic procedure
Item
no other serious diseases which conflict with the treatment in the present trial
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
Therapeutic procedure Interferes with Clinical Trial Therapeutic procedure
Item
no concurrent treatments that conflict with the treatments in the present trial
boolean
C0087111 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
voluntary participation | Informed Consent
Item
voluntary participation and signed the informed consent.
boolean
C0680274 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Tachycardia, Ventricular | Atrial Fibrillation | Heart Block | Myocardial Infarction | Congestive heart failure | Coronary heart disease Symptomatic
Item
the patients had the conditions below: clinically significant ventricular tachycardia (vt), atrial fibrillation (af), heart block, myocardial infarction (mi), congestive heart failure (chf), symptomatic coronary artery heart disease requiring medication;
boolean
C0042514 (UMLS CUI [1])
C0004238 (UMLS CUI [2])
C0018794 (UMLS CUI [3])
C0027051 (UMLS CUI [4])
C0018802 (UMLS CUI [5])
C0010068 (UMLS CUI [6,1])
C0231220 (UMLS CUI [6,2])
Study Subject Participation Status
Item
the patients participated in other clinical trials within the 30 days before enrollment or who are participating in other clinical studies
boolean
C2348568 (UMLS CUI [1])
Neuropathy
Item
the patients with neuropathy
boolean
C0442874 (UMLS CUI [1])
Mental disorders Informed Consent Unable
Item
the patients with mentally ill / unable to obtain informed consent
boolean
C0004936 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Substance Use Disorders Affecting Evaluation of test results Long-term
Item
the patients with drug addiction, alcohol abuse which affects the long-term evaluation of test results
boolean
C0038586 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C1285276 (UMLS CUI [1,3])
C0443252 (UMLS CUI [1,4])
Pregnancy | Breast Feeding | Childbearing Potential Age | Contraceptive methods Unwilling
Item
the patients in pregnancy, lactation and women of childbearing age who do not want to take contraceptive measures subjects
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0001779 (UMLS CUI [3,2])
C0700589 (UMLS CUI [4,1])
C0558080 (UMLS CUI [4,2])
Hypersensitivity Investigational New Drugs
Item
the patients with a history of allergy to test drug
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Study Subject Participation Status
Item
the patients not suitable to participate in the investigator judged by researchers.
boolean
C2348568 (UMLS CUI [1])